FULSPANS Trademark

Trademark Overview

On Thursday, November 20, 2014, a trademark application was filed for FULSPANS with the United States Patent and Trademark Office. The USPTO has given the FULSPANS trademark a serial number of 86460410. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, August 26, 2022. This trademark is owned by Glaxo Group Limited. The FULSPANS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
fulspans

General Information

Serial Number86460410
Word MarkFULSPANS
Filing DateThursday, November 20, 2014
Status710 - CANCELLED - SECTION 8
Status DateFriday, August 26, 2022
Registration Number4900313
Registration DateTuesday, February 16, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 1, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Pseudo MarkFULL SPANS
Translation of Words in MarkThe wording "FULSPANS" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, August 26, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Wednesday, November 9, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, November 9, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 9, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, November 9, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 9, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 9, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, August 26, 2022CANCELLED SEC. 8 (6-YR)
Tuesday, February 16, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, December 10, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, December 10, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 16, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, December 1, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 1, 2015PUBLISHED FOR OPPOSITION
Wednesday, November 11, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, October 23, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, October 20, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 20, 2015EXAMINER'S AMENDMENT ENTERED
Tuesday, October 20, 2015NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, October 20, 2015EXAMINERS AMENDMENT E-MAILED
Tuesday, October 20, 2015EXAMINERS AMENDMENT -WRITTEN
Thursday, October 15, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 15, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 8, 2015ASSIGNED TO LIE
Monday, September 21, 2015TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, September 16, 2015NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, September 16, 2015INQUIRY TO SUSPENSION E-MAILED
Wednesday, September 16, 2015SUSPENSION INQUIRY WRITTEN
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 16, 2015NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, March 16, 2015LETTER OF SUSPENSION E-MAILED
Monday, March 16, 2015SUSPENSION LETTER WRITTEN
Tuesday, March 10, 2015ASSIGNED TO EXAMINER
Tuesday, December 2, 2014NOTICE OF PSEUDO MARK E-MAILED
Saturday, November 29, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, November 24, 2014NEW APPLICATION ENTERED IN TRAM

Related Keywords

fulspans pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological